SILVAGNI, Ettore
 Distribuzione geografica
Continente #
NA - Nord America 2.459
AS - Asia 2.249
EU - Europa 885
SA - Sud America 356
AF - Africa 219
OC - Oceania 27
AN - Antartide 1
Totale 6.196
Nazione #
US - Stati Uniti d'America 2.308
SG - Singapore 833
CN - Cina 435
IT - Italia 270
BR - Brasile 219
HK - Hong Kong 200
DE - Germania 147
ID - Indonesia 139
EG - Egitto 134
GB - Regno Unito 130
IN - India 98
VN - Vietnam 98
MX - Messico 82
IQ - Iraq 73
TR - Turchia 62
CA - Canada 58
JP - Giappone 56
RU - Federazione Russa 46
FI - Finlandia 45
EC - Ecuador 43
IR - Iran 41
FR - Francia 40
PH - Filippine 35
NL - Olanda 34
PK - Pakistan 33
PL - Polonia 33
AU - Australia 27
ZA - Sudafrica 27
AR - Argentina 25
AT - Austria 22
KR - Corea 22
PE - Perù 22
SA - Arabia Saudita 22
UA - Ucraina 22
BD - Bangladesh 19
TW - Taiwan 19
ES - Italia 18
MY - Malesia 17
SE - Svezia 14
CO - Colombia 13
NG - Nigeria 12
BO - Bolivia 11
CZ - Repubblica Ceca 11
CL - Cile 10
KE - Kenya 10
BE - Belgio 9
DZ - Algeria 9
MA - Marocco 9
VE - Venezuela 9
CH - Svizzera 8
RO - Romania 8
PS - Palestinian Territory 7
JO - Giordania 5
LT - Lituania 5
GR - Grecia 4
HN - Honduras 4
IE - Irlanda 4
IL - Israele 4
KZ - Kazakistan 4
AZ - Azerbaigian 3
DK - Danimarca 3
HU - Ungheria 3
LB - Libano 3
LY - Libia 3
MM - Myanmar 3
OM - Oman 3
PT - Portogallo 3
TH - Thailandia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BF - Burkina Faso 2
KG - Kirghizistan 2
LS - Lesotho 2
LV - Lettonia 2
MG - Madagascar 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
TT - Trinidad e Tobago 2
UG - Uganda 2
AQ - Antartide 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PY - Paraguay 1
RE - Reunion 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZW - Zimbabwe 1
Totale 6.196
Città #
Singapore 459
Dallas 340
Ashburn 316
Santa Clara 220
Hong Kong 180
Beijing 175
Fairfield 108
Chandler 102
Los Angeles 83
Jakarta 76
Woodbridge 65
Alexandria 52
Houston 47
Seattle 42
Ho Chi Minh City 41
Wilmington 40
Cambridge 37
Cairo 35
Ferrara 35
Munich 34
Ann Arbor 33
Mexico City 33
Shanghai 32
Tokyo 31
Baghdad 30
New York 30
London 28
Princeton 28
São Paulo 28
Warsaw 28
Hanoi 24
Hefei 24
Helsinki 24
Montreal 23
Atlanta 22
Chicago 22
Frankfurt am Main 20
Bologna 19
Buffalo 19
Brooklyn 18
Izmir 18
Jacksonville 18
Nanjing 17
Denver 16
Falkenstein 16
Poplar 16
Quito 16
Toronto 16
Milan 15
Boston 14
Manchester 14
Najaf 14
San Diego 14
Lappeenranta 13
Lima 13
Nuremberg 13
Padova 13
Sydney 13
Ankara 12
Athens 12
Johannesburg 12
Phoenix 12
Chennai 10
City of London 10
Council Bluffs 10
Guayaquil 10
Hillah 10
Miami 10
Rome 10
Stockholm 10
Vienna 10
Delhi 9
Lahore 9
Medan 9
Moscow 9
Naples 9
Secaucus 9
Tanta 9
Brussels 8
Kuala Lumpur 8
Melbourne 8
Milwaukee 8
Orem 8
Rio de Janeiro 8
Surabaya 8
Addison 7
Bengaluru 7
Boardman 7
Edinburgh 7
Manila 7
Mérida 7
Nairobi 7
New Delhi 7
Osaka 7
Riyadh 7
Taipei 7
Amsterdam 6
Assago 6
Belo Horizonte 6
Brno 6
Totale 3.630
Nome #
Systemic lupus erythematosus: one year in review 2023 790
Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence 302
The diagnosis and clinical management of the neuropsychiatric manifestations of lupus 245
Novel insights into the management of rheumatoid arthritis: one year in review 2022 225
Novel insights into the management of rheumatoid arthritis: one year in review 2023 204
Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases 174
Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study 155
Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology 154
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome 149
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology 136
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus 130
Biological and synthetic target DMARDs in psoriatic arthritis 127
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 124
Comparison of the risks of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanercept 122
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 119
One year in review 2018: novelties in the treatment of rheumatoid arthritis 117
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 115
Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis 113
Optimizing Patient Care: A Systematic Review of Multidisciplinary Approaches for SLE Management 111
Adherence of Italian rheumatologists to the EULAR recommendations and outcomes in early rheumatoid arthritis patients after starting conventional DMARDs: Methotrexate in Italian patients wiTh Rheumatoid Arthritis (the MITRA study). A cohort study of the Italian Society for Rheumatology 110
Conventional brain magnetic resonance imaging in the longitudinal evaluation of newly diagnosed systemic lupus erythematosus patients: a retrospective analysis from a single-centre cohort 108
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis 107
Tofacitinib improves mitochondrial function in psoriatic arthritis fibroblast-like synoviocytes via autophagy modulation 107
Methotrexate in Italian patients wiTh Rheumatoid Arthritis (MITRA study): an observational study about the use of methotrexate in early RA patients and the adherence to the EULAR 2013 recommendations. A project of the Italian Society for Rheumatology 101
Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis 100
High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study 99
Cerebral Microstructure Analysis by Diffusion-Based MRI in Systemic Lupus Erythematosus: Lessons Learned and Research Directions 95
Tofacitinib restores psoriatic arthritis fibroblast-like synoviocytes function via autophagy and mitochondrial quality control modulation 93
Serum Antibodies Against the Oncogenic Merkel Cell Polyomavirus Detected by an Innovative Immunological Assay With Mimotopes in Healthy Subjects 92
Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review 88
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 85
Therapeutic Strategies and Outcomes in Neuropsychiatric Systemic Lupus Erythematosus: An International Multicenter Retrospective Study 84
Features associated with different inflammatory phenotypes of calcium pyrophosphate deposition (CPPD) disease: study using data from the international ACR/EULAR CPPD classification criteria cohort 82
Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review 79
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles 79
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression 77
Risk of hospitalisation for serious bacterial infections in patients with rheumatoid arthritis treated with biologics. Analysis from the RECord linkage On Rheumatic Disease study of the Italian Society for Rheumatology 75
Systemic lupus erythematosus: one year in review 2024 74
Can conventional brain MRI support the attribution process in neuropsychiatric SLE? A multicentre retrospective study 73
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 72
One year in review 2019: novelties in the treatment of rheumatoid arthritis 71
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease 67
One year in review 2021: novelties in the treatment of rheumatoid arthritis 67
The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease 59
Rheumatoid Arthritis and Cardiovascular Risk: Retrospective Matched-Cohort Analysis Based on the RECORD Study of the Italian Society for Rheumatology 59
Musculoskeletal ultrasound for treating rheumatoid arthritis to target—a systematic literature review 59
Neurologic Involvement in Rheumatic Diseases 57
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study 55
Role of comorbidities on therapeutic persistence of biological agents in rheumatoid arthritis: results from the RECord-linkage On Rheumatic Disease study on administrative healthcare databases 55
One year in review 2020: novelties in the treatment of rheumatoid arthritis 51
Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology 47
Clinical application of synovial biopsy in noninflammatory and persistent inflammatory refractory rheumatoid arthritis 47
SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study 47
Systemic lupus erythematosus: one year in review 2025 42
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage 42
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus 24
Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohort 18
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0) 12
Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology 1
Totale 6.372
Categoria #
all - tutte 33.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 183
Totale 33.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 0 0 0 0 0 11 11 17 13 23 17 9
2021/2022247 12 34 10 11 10 6 29 21 16 8 14 76
2022/2023245 26 32 15 18 39 17 6 21 27 4 20 20
2023/2024610 21 23 13 8 56 6 9 18 25 140 115 176
2024/20252.172 82 150 200 140 222 252 96 110 343 195 226 156
2025/20262.621 431 210 622 498 784 76 0 0 0 0 0 0
Totale 6.372